- Report
- October 2024
- 185 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 192 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- November 2023
- 98 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2023
- 146 Pages
Global
From €3367EUR$3,528USD£2,821GBP
€3961EUR$4,150USD£3,318GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2019
- 340 Pages
Global
From €4152EUR$4,350USD£3,478GBP
- Report
- September 2024
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2024
Global
From €4152EUR$4,350USD£3,478GBP
- Report
- December 2022
- 375 Pages
Global
From €3407EUR$3,570USD£2,855GBP
The Lipid Test market is a subset of the Cholesterol Testing market. It is composed of tests that measure the levels of lipids, such as triglycerides, HDL, and LDL, in the blood. These tests are used to assess the risk of cardiovascular disease and other health conditions. Lipid tests are typically ordered by physicians as part of a routine physical exam or when a patient has risk factors for cardiovascular disease.
The Lipid Test market is highly competitive, with a variety of companies offering tests and services. Some of the major players in the market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostics, and Alere. These companies offer a range of tests and services, including point-of-care testing, laboratory testing, and home testing. Show Less Read more
